Telemetry Investments’s Aimmune Therapeutics AIMT Stock Holding History

Telemetry Investments’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,500	Closed	-$534K	–	102
2020 Q3	$534K	Buy	+15,500	New	+$330K	1.16%	38

Telemetry Investments's AIMT Position: Q4 2020 in Review

Telemetry Investments sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 15,500 shares — an estimated $534K sold.

Telemetry Investments first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $534K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Telemetry Investments reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Telemetry Investments sold 15,500 Aimmune Therapeutics shares in Q4 2020, an estimated $534K.
Telemetry Investments first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Telemetry Investments's Aimmune Therapeutics position peaked at $534K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Telemetry Investments's 13F filing for Q4 2020, filed 16 Feb 2021.